RCM

RA Capital Management Portfolio holdings

AUM $9.76B
1-Year Est. Return 103.63%
This Fund
S&P 500
This Quarter Est. Return
1 Year Est. Return
+103.63%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$5.94B
AUM Growth
-$52.2M
Cap. Flow
Cap. Flow %
Top 10 Hldgs %
Holding
90
New
Increased
Reduced
Closed

Top Buys

1
+$54.6M
2
+$28.8M
3
+$27.6M
4
JBIO
Jade Biosciences
JBIO
+$27.2M
5
TYRA icon
Tyra Biosciences
TYRA
+$14.8M

Top Sells

1
+$58.6M
2
+$46.8M
3
+$45.6M
4
URGN icon
UroGen Pharma
URGN
+$35.5M
5
RYTM icon
Rhythm Pharmaceuticals
RYTM
+$32M

Sector Composition

1 Healthcare 99.82%
2 Financials 0.13%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
26
$53.4M 0.9%
2,866,733
27
$48.1M 0.81%
3,702,967
-40,051
28
$40.6M 0.68%
2,538,925
29
$40.3M 0.68%
1,136,453
30
$39M 0.66%
31,419,267
31
$31.5M 0.53%
1,517,418
32
$28.3M 0.48%
5,811,323
+1,480,877
33
$19.2M 0.32%
675,525
34
$18.3M 0.31%
511,207
35
$17.9M 0.3%
10,805,129
36
$17.5M 0.29%
6,045,351
37
$17.3M 0.29%
14,932,063
38
$17M 0.29%
848,986
39
$17M 0.29%
1,150,000
40
$16.9M 0.29%
4,563,211
41
$15.5M 0.26%
+300,000
42
$14.9M 0.25%
9,853,302
43
$11.9M 0.2%
10,689,545
44
$10.6M 0.18%
1,062,326
+799,695
45
$10.2M 0.17%
+2,000,000
46
$9.93M 0.17%
8,340,508
47
$9.66M 0.16%
3,566,338
48
$9.25M 0.16%
1,136,364
49
$7.96M 0.13%
750,000
50
$7.32M 0.12%
+400,000
1
2
3 4